How Long Should Myeloma Patients Continue Lenalidomide After AutoSCT?

(MedPage Today) -- Data from a large phase III trial presented at the 2022 American Society of Hematology (ASH) annual meeting examined the relationship between minimal residual disease, progression-free survival, and overall survival in patients...